top of page

Adverse Effects and Safety of Roaccutane (Isotretinoin): What Every Doctor Should Know for PLAB 2

Introduction

Isotretinoin, commonly known by the brand name Roaccutane, is a retinoid medication highly effective in treating severe, resistant acne. While it is considered a “game changer” in dermatology, it is also one of the most tightly regulated drugs due to its serious adverse effects and teratogenicity.

In the UK, oral isotretinoin is licensed and prescribed only by dermatologists under strict monitoring protocols. Topical isotretinoin products exist internationally but are not licensed or available in the UK. Instead, NICE recommends other topical retinoids such as adapalene or tretinoin for first-line management of acne in primary care.

This blog will outline the adverse effects, contraindications, and monitoring requirements of isotretinoin, highlighting the differences between the oral and topical forms.


🧴 Topical Isotretinoin: Adverse Effects

Although not used in UK practice, it’s important to recognise possible adverse effects where topical isotretinoin is available (e.g., some non-UK markets).

Adverse effects include:

  • Skin reactions: blistering, burning, crusting, dryness, peeling, erythema (redness).

  • Ocular irritation: eye irritation, conjunctival dryness.

  • Photosensitivity: increased sensitivity to UVA and UVB light.

  • Other local reactions: edema (swelling), pruritus (itching), stinging.

👉 Because of these side effects, UK guidelines favour topical adapalene or tretinoin instead, which offer similar efficacy with a better safety profile.


🇬🇧 Why Topical Isotretinoin is Not Used in UK Primary Care

  • Licensing: Only oral isotretinoin is licensed in the UK, specifically for severe acne resistant to standard therapies.

  • Availability: Topical isotretinoin products are available in certain countries but are not marketed or licensed in the UK.

  • Guideline Recommendations: According to NICE (NG198), first-line topical treatments include adapalene, tretinoin, and benzoyl peroxide, not isotretinoin.

📌 Summary: UK GPs cannot prescribe topical isotretinoin. Instead, topical retinoids like adapalene are preferred and widely used.


💊 Oral Roaccutane (Isotretinoin): Adverse Effects

Common Side Effects

  • Skin and mucosal dryness: dry lips, dry eyes, dry skin.

  • Epistaxis: nosebleeds due to nasal mucosa dryness.

  • Photosensitivity: skin burns easily in sunlight.

  • Musculoskeletal: muscle aches and joint pains.

  • Biochemical changes: raised cholesterol, triglycerides, and sometimes deranged liver enzymes.

  • Acne flare: temporary worsening of acne in the first few weeks.

Serious Adverse Effects

  • Skin: severe skin reactions (rare, but possible).

  • Liver: hepatotoxicity, abnormal LFTs.

  • Metabolic: hyperlipidaemia, hyperglycaemia.

  • Gastrointestinal: risk of inflammatory bowel disease (rare).

  • Neuropsychiatric: depression, mood changes, suicidal ideation.

  • Pregnancy: severe teratogenic effects — craniofacial, cardiac, CNS malformations, miscarriage risk.


🚫 Contraindications of Oral Isotretinoin

  • Absolute:

    • Pregnancy (teratogenicity).

    • Breastfeeding.

    • Severe liver disease.

    • Hyperlipidaemia.

    • Hypervitaminosis A.

  • Drug interactions:

    • Tetracycline antibiotics (risk of pseudotumour cerebri).

  • Relative contraindications:

    • Severe kidney impairment.

    • History of psychiatric illness (requires close monitoring).


🩺 Monitoring and Precautions

Because of the serious risks, oral isotretinoin requires strict monitoring:

  • Baseline tests before starting:

    • Liver function tests (LFTs).

    • Fasting lipid profile (cholesterol, triglycerides).

    • Blood glucose (if risk factors present).

    • Pregnancy test (in women of childbearing potential).

  • During treatment:

    • Repeat LFTs and lipid profile after 1 month, then every 3 months.

    • Pregnancy tests monthly for women of childbearing age.

    • Monitor for mood changes and psychological health.

  • Lifestyle precautions:

    • Avoid vitamin A supplements (risk of hypervitaminosis A).

    • Avoid waxing during and 6 months post-treatment (risk of scarring).

    • Use sunscreen and avoid excessive sun exposure.

    • Avoid donating blood during treatment and for 1 month after (risk to pregnant recipients).


Conclusion

  • Topical isotretinoin: Not licensed in the UK, associated with significant skin irritation. NICE instead recommends adapalene or tretinoin as first-line topical retinoids.

  • Oral isotretinoin (Roaccutane): A highly effective treatment for severe acne, but restricted to specialist dermatologists due to its serious adverse effects and teratogenicity. Requires regular blood monitoring, pregnancy testing, and patient counselling.

  • Clinical relevance for PLAB 2 / UK practice: As a GP, you cannot prescribe oral isotretinoin. Instead, you initiate first-line topical or oral antibiotics/hormonal therapy and refer to dermatology if acne is severe, resistant, or causing scarring/psychological harm.


📚 References

Comments

bottom of page